Seeking men and women whose non-small cell lung cancer has come back or spread after treatment for a study of an investigational drug that is targeted for tumors with a specific biologic marker.
We are studying whether the investigational drug is safe and effective in reducing the growth or spread of non-small cell lung cancer in people whose tumor has a specific genetic biomarker. We are evaluating whether the investigational drug could shrink your cancer and if the biomarker test is helpful in deciding which drugs to prescribe.
What we're hoping for
Evaluate the safety and effectiveness of an investigational drug in reducing the growth or spread of advanced non-small cell lung cancer in people who have RET Fusion-Positive tumors.
ClinicalTrials.gov Identifier: NCT04268550